Nagarajan Pattabiraman

Seasoned leader and innovator with extensive experience across academia and industry, notably at Walter Reed Army Institute of Research. Excelled in strategic planning and revenue generation, driving significant growth. Skilled in consulting and human resources, adept at translating research into actionable strategies. Achieved a notable increase in efficiency and productivity, demonstrating a unique blend of technical and interpersonal skills.

Nagarajan, Pattabiraman, NPATTABIRAMAN, President, MolBox, LLC, University of Madras, Madras, India, BSc, 06/72, Physics, Chemistry, Math, University of Madras, Madras, India, MS, 06/74, Nuclear Physics, Indian Institute of Science, Bangalore, India, PhD, 07/79, Molecular Biophysics, University of California, San Francisco, San Francisco, CA, Postdoc, 06/84, Computational Chemistry, Founder/President, MolBox LLC, 8115 Fenton Street Suite 304, Silver Spring, MD, 20910, 2009-01-01, Senior Research Chemist (Contract Research), Department of Structural and Molecular Biology, Division of Bacterial & Rickettsial Diseases, Walter Reed Army Institute of Research, Silver Spring, MD, 2008-01-01, 2011-01-01, Research Associate Professor, Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 2007-01-01, 2009-01-01, Senior Research Chemist (Contract Research), Department of Biochemistry, Molecular Pharmacology Division, Walter Reed Army Institute of Research, Silver Spring, MD, 2006-01-01, 2008-01-01, Research Associate Professor, Departments of Oncology and Biochemistry & Molecular Biology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, 2002-01-01, 2005-01-01, Guest Researcher, Laboratory for Experimental and Computational Biology, National Cancer Institute, Frederick, MD, 2002-01-01, 2005-01-01, Scientist, AstraZeneca Inc., Department of Chemistry, Wilmington, DE, 2001-01-01, 2002-01-01, Scientific Applications Analyst, Advanced Biomedical Computing Center, SAIC, NCI-Frederick Cancer Center, Frederick, MD, 1993-01-01, 2001-01-01, Adjunct Associate Professor, Department of Biochemistry & Molecular Biology, Georgetown University, Washington, DC, 1993-01-01, 1995-01-01, Senior Scientist, Geo-Centers, Laboratory of Structure of Matter, Naval Research Laboratory, Washington, DC, 1987-01-01, 1993-01-01, Assistant Research Chemist, Department of Pharmaceutical Chemistry, University of California, San Francisco, CA, 1984-01-01, 1987-01-01, Norman P. Salzman Mentoring Award, 1999, In Recognition of a devoted scientist for his lifetime commitment to the guidance and direction of others in the pursuit of scientific excellence, Indian National Science Academy Young Scientist Award, 1980, Kothari Scientific and Research Institute Cash Awards, India, Senior Research Fellowship, 1978-1979, From Indian Institute of Science, India, Junior Research Fellowship, 1974-1978, From UGC, New Delhi, India, The Madras University Centenary Delhi Prize, 1974, The Dr. K. S. Krishnan Memorial Prize, 1974, The Professor P. E. S. Ayyar Commemoration Medal, 1974, The Jagirdar of Arni Medal I, 1974, The Dr. K. S. Krishnan Gold Medal, 1974, Jones Memorial Senior Prize, 1974, Sitalakshmi Subramaniya Prize, 1974, Dr. H. Parameswarn Memorial Senior Prize, 1974, Post–Matric Merit Scholarship, 1968-1974, Of Government of Pondicherry, India, Developed inhibitors for cancer targets including Stat5, CDK1, VEGFR, HIF-2, SIRT1, viral protease target of DENG virus, and bacterial targets., Developed a class of novel reactivators against nerve agents., Developed a grid-based docking method for in-silico screening of compounds against protein targets., Structure–Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia, Liao Z, Gu L, Vergalli J, Mariani SA, De Dominici M, Lokareddy RK, Dagvadorj A, Purushottamachar P, McCue PA, Trabulsi E, Lallas CD, Gupta S, Ellsworth E, Blackmon S, Ertel A, Fortina P, Leiby B, Xia G, Rui H, Hoang DT, Gomella LG, Cingolani G, Njar V, Pattabiraman N, Calabretta B, Nevalainen MT, Mol Cancer Ther, 08/15, 14, 8, 1777–93, PMC4547362, Prospects for clinical development of Stat5 inhibitor IST5-002: High transcriptomic specificity in prostate cancer and low toxicity in vivo, Maranto C, Udhane V, Jing J, Verma RS, Fahrenkamp D, Muller-Newen G, LaViolette PS, Pereckas M, Sabharwal L, Terhune S, Pattabiraman N, Njar VCO, Imig JD, Wang L, Nevalainen MT, Cancers (Basel), 11/20, 12, 11, 3412, 10.3390/cancers12113412, 33217941